Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 66 citing articles:

Nanoparticle-Based Vaccines Against Respiratory Viruses
Al Halifa Soultan, Laurie Gauthier, Dominic Arpin, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 263
Intranasal COVID-19 vaccines: From bench to bed
Aqu Alu, Li Chen, Lei Hong, et al.
EBioMedicine (2022) Vol. 76, pp. 103841-103841
Open Access | Times Cited: 214
Chitosan for gene delivery: Methods for improvement and applications
Di Chuan, Tao Jin, Rangrang Fan, et al.
Advances in Colloid and Interface Science (2019) Vol. 268, pp. 25-38
Closed Access | Times Cited: 180
Combinatorial development of nebulized mRNA delivery formulations for the lungs
Allen Yujie Jiang, Jacob Witten, Idris O. Raji, et al.
Nature Nanotechnology (2023) Vol. 19, Iss. 3, pp. 364-375
Open Access | Times Cited: 52
The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects
Bowen Lu, Jing Ming Lim, Boyue Yu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 41
DNA vaccines as promising immuno-therapeutics against cancer: a new insight
Alireza Shariati, Arya Khezrpour, Fatemeh Sadat Shariati, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 2
Engineered Nanodelivery Systems to Improve DNA Vaccine Technologies
Michael Lim, Abu Zayed Md Badruddoza, Jannatul Firdous, et al.
Pharmaceutics (2020) Vol. 12, Iss. 1, pp. 30-30
Open Access | Times Cited: 97
The Application of Mucoadhesive Chitosan Nanoparticles in Nasal Drug Delivery
Soojin Shim, Han Sang Yoo
Marine Drugs (2020) Vol. 18, Iss. 12, pp. 605-605
Open Access | Times Cited: 87
Chitosan, N,N,N-trimethyl chitosan (TMC) and 2-hydroxypropyltrimethyl ammonium chloride chitosan (HTCC): The potential immune adjuvants and nano carriers
Jing Zhao, Jinqi Li, Zhongliang Jiang, et al.
International Journal of Biological Macromolecules (2020) Vol. 154, pp. 339-348
Closed Access | Times Cited: 76
Methods to improve the immunogenicity of plasmid DNA vaccines
Dalinda Eusébio, Ana R. Neves, Diana Costa, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 11, pp. 2575-2592
Closed Access | Times Cited: 68
Chitosan-Based Nanomaterial as Immune Adjuvant and Delivery Carrier for Vaccines
Xiaochen Gong, Yuan Gao, Jianhong Shu, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1906-1906
Open Access | Times Cited: 55
Current status of mannose receptor-targeted drug delivery for improved anti-HIV therapy
Satish Rojekar, Amol D. Gholap, Namdev Togre, et al.
Journal of Controlled Release (2024) Vol. 372, pp. 494-521
Closed Access | Times Cited: 12
Topical review on nano-vaccinology: Biochemical promises and key challenges
Tean Zaheer, Kaushik Pal, Iqra Zaheer
Process Biochemistry (2020) Vol. 100, pp. 237-244
Open Access | Times Cited: 54
IgA and FcαRI: Versatile Players in Homeostasis, Infection, and Autoimmunity
Melissa M. J. van Gool, Marjolein van Egmond
ImmunoTargets and Therapy (2021) Vol. Volume 9, pp. 351-372
Open Access | Times Cited: 41
Nanotechnologies in Delivery of DNA and mRNA Vaccines to the Nasal and Pulmonary Mucosa
Jie Tang, Larry Cai, Chuanfei Xu, et al.
Nanomaterials (2022) Vol. 12, Iss. 2, pp. 226-226
Open Access | Times Cited: 35
Mannose in vaccine delivery
Ummey Jannatun Nahar, István Tóth, Mariusz Skwarczyński
Journal of Controlled Release (2022) Vol. 351, pp. 284-300
Closed Access | Times Cited: 34
Nanomaterial-based delivery of vaccine through nasal route: Opportunities, challenges, advantages, and limitations
Mohit Kumar, Raghav Dogra, Uttam Kumar Mandal
Journal of Drug Delivery Science and Technology (2022) Vol. 74, pp. 103533-103533
Closed Access | Times Cited: 28
Immune interference in effectiveness of influenza and COVID-19 vaccination
Yiwen Xie, Xuebin Tian, Xiaodi Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Exploration of chitosan and its modified derivatives as vaccine adjuvant: A review
Girish Kumar, Tarun Virmani, Shashi Kiran Misra, et al.
Carbohydrate Polymer Technologies and Applications (2024) Vol. 8, pp. 100537-100537
Open Access | Times Cited: 6
Chitosan biopolymer, its derivatives and potential applications in nano-therapeutics: A comprehensive review
Mahwash Mukhtar, Eszter Fényes, Csilla Bartos, et al.
European Polymer Journal (2021) Vol. 160, pp. 110767-110767
Closed Access | Times Cited: 38
DNA vaccine encoding OmpA and Pal from Acinetobacter baumannii efficiently protects mice against pulmonary infection
Langhuan Lei, Feng Yang, Jintao Zou, et al.
Molecular Biology Reports (2019) Vol. 46, Iss. 5, pp. 5397-5408
Open Access | Times Cited: 41
Mannosylated chitosan nanoparticles loaded with FliC antigen as a novel vaccine candidate against Brucella melitensis and Brucella abortus infection
Zohre Sadeghi, Mahdi Fasihi‐Ramandi, Mohammad Azizi, et al.
Journal of Biotechnology (2020) Vol. 310, pp. 89-96
Closed Access | Times Cited: 36
Nanoparticles for mucosal vaccine delivery
Aneesh Thakur, Camilla Foged
Elsevier eBooks (2020), pp. 603-646
Closed Access | Times Cited: 33
RNA nanotechnology: A new chapter in targeted therapy
Tongtong Lv, Yingying Meng, Yifan Liu, et al.
Colloids and Surfaces B Biointerfaces (2023) Vol. 230, pp. 113533-113533
Closed Access | Times Cited: 12
Inhalation drug delivery in combating pulmonary infections: Advances and challenges
Popat Kumbhar, Jaskiran Kaur, Gabriele De Rubis, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 89, pp. 105022-105022
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top